Garber Alan M
- SEC CIK
- 0001312907
No open-market purchases or sales filed in the past year.
Current role at each company
- VRTX Vertex Pharmaceuticals IncDirectoras of Jul 17, 2026
- EXEL Exelixis, Inc.Directoras of Mar 25, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Garber Alan M as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
EXEL Exelixis, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2024 (view filing) | Mar 21 | 4 days | Garber Alan MDirector | SSale | −19.2K | $24.01 | −$461.1K | −35.0%35.7K after | 10b5-1 |
| Feb 23, 2023 (view filing) | Feb 21 | 2 days | Garber Alan MDirector | SSale | −40.0K | $17.49 | −$699.6K | −56.0%31.4K after | |
| Mar 3, 2022 (view filing) | Mar 1 | 2 days | Garber Alan MDirector | SSale | −21.3K | $21.00 | −$447.3K | −40.4%31.4K after |